Platelet storage and transfusions: New concerns associated with an old therapy

Drug Discovery Today: Disease Mechanisms

Volumn 8, Issue 1-2, 2011, Pages

  Sahler, Julie ^a   Grimshaw, Katie ^a   Spinelli, Sherry L ^a   Refaai, Majed A ^a   Phipps, Richard P ^a,b   Blumberg, Neil ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; RANTES;

BLOOD GROUP ABO SYSTEM; HUMAN; IMMUNITY; INFLAMMATION; MORBIDITY; MORTALITY; RECIPIENT; REVIEW; SAFETY; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOSIS;

EID: 84859802978     PISSN: None     EISSN: 17406765     Source Type: Journal    
DOI: 10.1016/j.ddmec.2011.06.001     Document Type: Review

References (40)

1. Sullivan, M.T. and Wallace, E.L. (2005) Blood collection and transfusion in the United States in 1999. Transfusion 45, 141-148 (Pubitemid 40180129)
2. Heddle, N.M. et al. (1993) A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 33, 794-797 (Pubitemid 23332497)
3. Apelseth, T.O. et al. (2006) Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion 46, 800-810
4. Konca, K. et al. (2006) The effect of cromoglycate on time-dependent histamine and serotonin concentrations in stored blood products. Transfus. Apher. Sci. 34, 193-198
5. Kaufman, J. et al. (2007) Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J. Thromb. Haemost. 5, 788-796 (Pubitemid 46563579)
6. Khan, S.Y. et al. (2006) Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108, 2455-2462 (Pubitemid 44497533)
7. Blumberg, N. et al. (2006) An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 46, 1813-1821 (Pubitemid 44435735)
8. Thon, J.N. et al. (2008) Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 48, 425-435 (Pubitemid 351294569)
9. Springer, D.L. et al. (2009) Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J. Proteome Res. 8, 2261-2272
10. Horstman, L.L. and Ahn, Y.S. (1999) Platelet microparticles: a wide-angle perspective. Crit. Rev. Oncol. Hematol. 30, 111-142 (Pubitemid 29232249)
11. Ratajczak, J. et al. (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495 (Pubitemid 44264090)
12. Barry, O.P. et al. (1997) Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J. Clin. Invest. 99, 2118-2127 (Pubitemid 27203768)
13. Feng, B. et al. (2009) Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis 208, 264-269
14. Nomura, S. (2009) Dynamic role of microparticles in type 2 diabetes mellitus. Curr. Diabetes Rev. 5, 245-251
15. Italiano, J.E., Jr et al. (2010) Clinical relevance of microparticles from platelets and megakaryocytes. Curr. Opin. Hematol.
16. Sugawara, A. et al. (2010) Preventing platelet-derived microparticle formation - and possible side effects - with prestorage leukofiltration of whole blood. Arch. Pathol. Lab. Med. 134, 771-775
17. Nomura, S. et al. (2000) Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes. Clin. Appl. Thromb. Hemost. 6, 213-221 (Pubitemid 33143852)
18. Leytin, V. and Freedman, J. (2003) Platelet apoptosis in stored platelet concentrates and other models. Transfus. Apher. Sci. 28, 285-295 (Pubitemid 36506504)
19. Mason, K.D. et al. (2007) Programmed anuclear cell death delimits platelet life span. Cell 128, 1173-1186 (Pubitemid 46427871)
20. Kaplan, J.E. and Saba, T.M. (1978) Platelet removal from the circulation by the liver and spleen. Am. J. Physiol. 235, H314-H320 (Pubitemid 9159904)
21. Santoso, S. et al. (1991) Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib. Thromb. Haemost. 65, 196-201
22. Ogasawara, K. et al. (1993) Study on the expression of ABH antigens on platelets. Blood 82, 993-999 (Pubitemid 23221686)
23. Slichter, S.J. et al. (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105, 4106-4114 (Pubitemid 40656162)
24. Pavenski, K. et al. (2010) Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study. Transfusion 50, 1552-1560
25. Heal, J.M. et al. (1993) The role of ABO matching in platelet transfusion. Eur. J. Haematol. 50, 110-117 (Pubitemid 23061276)
26. Petz, L.D. et al. (2000) Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 40, 1446-1456 (Pubitemid 32048531)
27. Duquesnoy, R.J. (2008) Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Transfusion 48, 221-227
28. Elzey, B.D. et al. (2005) The emerging role of platelets in adaptive immunity. Cell Immunol. 238, 1-9 (Pubitemid 43288027)
29. Davi, G. and Patrono, C. (2007) Platelet activation and atherothrombosis. N. Engl. J. Med. 357, 2482-2494
30. Mause, S.F. et al. (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler. Thromb. Vasc. Biol. 25, 1512-1518 (Pubitemid 40923377)
31. McNicol, A. and Israels, S.J. (2008) Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc. Hematol. Disord. Drug Targets 8, 99-117
32. Silliman, C.C. and McLaughlin, N.J. (2006) Transfusion-related acute lung injury. Blood Rev. 20, 139-159
33. Heddle, N.M. et al. (1994) The role of the plasma from platelet concentrates in transfusion reactions. N. Engl. J. Med. 331, 625-628 (Pubitemid 24276861)
34. Angiolillo, D.J. et al. (2010) Basic principles of platelet biology and clinical implications. Circ. J. 74, 597-607
35. Khorana, A.A. et al. (2008) Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch. Intern. Med. 168, 2377-2381
36. de Boer, M.T. et al. (2008) The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth. Analg. 106, 32-44
37. Spiess, B.D. et al. (2004) Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44, 1143-1148 (Pubitemid 38989746)
38. Vo, T.D. et al. (2001) Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfus. Med. 11, 45-47 (Pubitemid 32180321)
39. Blumberg, N. et al. (2010) An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 50, 2738-2744
40. Blumberg, N. et al. (2004) A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord. 4, 6